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Mammalian CtIP protein plays major roles in DNA double-strand break (DSB) repair. While it 
is well established that CtIP promotes DNA-end resection in preparation for homology-
dependent DSB repair, the molecular basis for this function remains unknown. Here we 
show by biophysical and X-ray crystallographic analyses that the N-terminal domain of 
human CtIP exists as a stable homotetramer. Tetramerisation results from interlocking 
interactions between the N-terminal extensions of the CtIP coiled coil region, leading to a 
‘dimer-of-dimers' architecture. Through interrogation of the structure, we identify a CtIP 
mutation that abolishes tetramerisation of the N-terminal domain while preserving its dimeric 
structure in vitro. Importantly, we establish that this mutation abrogates CtIP oligomer 
assembly in cells, leading to strong defects in DNA-end resection and gene conversion. 
These findings indicate that a CtIP tetramer architecture is essential for effective DSB repair 
by homologous recombination. 
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The successful repair of DNA lesions is essential for cellular survival and the prevention of 
cancer1. Double-strand breaks (DSBs) are highly dangerous DNA lesions that are induced 
by various exogenous and endogenous agents, including ionising radiation and collapsed 
DNA replication forks. During late S and G2 phases of the cell cycle, high-fidelity repair of 
DSBs is promoted by homologous recombination (HR), in which the newly synthesised sister 
chromatid acts as a DNA repair template2. In contrast, during G1 and early S phases, the 
lack of a suitable homologous template means that DSBs must be repaired by the error-
prone mechanism of non-homologous end joining (NHEJ)3. Optimal maintenance of genomic 
integrity thus depends on the successful execution of HR and NHEJ, and the appropriate 
choice of DSB repair pathway on the basis of cell cycle stage. 
CtIP/RBBP8 was initially identified as a binding partner of the retinoblastoma protein (RB1)4, 
CtBP (C-terminal binding protein 1)5 and BRCA16, and as a transcription factor with 
regulatory functions in G1/S cell cycle progression and DNA damage-induced activation of 
the G2/M checkpoint7-10. Subsequent studies revealed its direct involvement in DNA DSB 
repair and the prevention of genomic instability11. It is now well established that CtIP plays 
key roles in DSB repair by HR and microhomology-mediated end joining (MMEJ)12-15. The 
DSB repair functions of CtIP are attributed to its role in promoting DNA-end resection, acting 
in functional and physical association with the MRE11-RAD50-NBS1 (MRN) complex11. CtIP 
recruitment to DSBs is required for effective formation of the RPA-coated 3'-ssDNA 
extensions that are a key intermediate in HR-mediated repair, and for activation of DNA-
damage signalling by the protein kinase ATR11,16. CtIP activity is regulated in a cell-cycle 
dependent manner, which affects the choice of DSB repair pathway: in S and G2 phases, 
cyclin-dependent kinase (CDK) phosphorylation of CtIP residues S327 (which is necessary 
for interaction with BRCA1) and T847 promotes HR12,13,17. In addition, CtIP is important for 
the limited DNA-end resection that promotes MMEJ during G1 phase12,14,15. 
Extensive regions of amino acid conservation among vertebrate CtIP sequences are 
observed only at the N- and C-terminal ends of the molecule. Limited conservation of the 
CtIP C-terminal region extends to Sae2, the functional homologue of CtIP in Saccharomyces 
cerevisiae, which contains a CDK phosphorylation site that is functionally analogous to T847 
of human CtIP13,17. The N- and C-terminal regions of CtIP are independently capable of 
interacting with the MRN complex, and deletion of either region is sufficient to abrogate the 
function of CtIP in DNA-end resection and G2/M checkpoint activation11,18. Primary sequence 
analysis of the conserved C-terminal region of CtIP has not provided clear insights into its 
mechanism of action, but it is likely to act as a recruitment module for macromolecular 
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interactions with protein and nucleic acids that are regulated by phosphorylation. In contrast, 
considerable α-helical structure is predicted for the N-terminal region, suggesting that it 
might mediate key aspects of CtIP structure and function. 
Biophysical studies in solution have provided evidence that amino acid residues 45 to 160 
are responsible for CtIP dimerisation via formation of an extended parallel coiled coil, 
interrupted in the middle by a putative zinc-binding motif Cys-X-X-Cys (residues 89-92, 
where X is any amino acid)19,20. However, recent evidence suggests that dimer formation is 
insufficient to explain the essential role of the CtIP N-terminal region in DNA repair, as 
deletion of residues 20-45 or 22-45, which precede the dimerisation domain, impairs DSB 
end-resection, HR, MMEJ and G2/M checkpoint activation18,21. Here, we demonstrate 
through biophysical and crystallographic analysis that the CtIP N-terminal region adopts a 
tetrameric structure, mediated by antiparallel association of helical extensions protruding 
from the N-termini of two parallel coiled-coil dimers. Furthermore, we show that a point 
mutation that disrupts tetramer formation, while retaining CtIP dimerisation, leads to failure of 
DNA-end resection and defective HR. We discuss potential functions for CtIP ‘dimer-of-
dimers’ assembly and why it is crucial for effective DNA repair. 
 
RESULTS 
The CtIP N-terminal region forms a tetramer 
To gain insight into the structure of the CtIP N-terminal domain (CtIP-NTD), we expressed 
the region spanning CtIP residues 18 to 145 in E. coli and purified it to homogeneity (Fig. 1a 
and Supplementary Fig. 1). Analysis by size-exclusion chromatography multi-angle light 
scattering (SEC-MALS) revealed that the CtIP-NTD forms a single tetrameric species 
corresponding to a molecular mass	   of	  68.7 kDa (Fig. 1b). Furthermore, we found that the 
tetrameric structure is almost entirely	   α-helical and shows high thermal stability 
(Supplementary Fig. 2a, b). Notably, we identified by microbeam proton-induced X-ray 
emission (microPIXE) analysis the presence of bound zinc with an estimated CtIP-NTD:Zn2+ 
ratio of 2:1 (Supplementary Fig. 3), a conclusion supported by spectrophotometric assays 
based on 4-(2-pyridylazo)resorcinol (PAR)22, where  zinc was detected at 40% of the molar 
protein concentration (Fig. 1c). Furthermore, PAR analysis of a C89 and C92 double alanine 
mutant (CtIP-NTD-DM) detected only background quantities of zinc (Fig. 1c), identifying C89 
and C92 as ligands for the metal. The tetrameric structure and α-helical content of CtIP-
NTD-DM were essentially the same as the non-mutated protein (Fig. 1b and 
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Supplementary Fig. 2a), indicating that zinc is not important for tetramerisation. These data 
thus established that the CtIP N-terminal domain adopts a helical tetrameric structure with 
two bound zinc ions. 
 
Defining the CtIP tetramerisation motif 
To identify the region mediating CtIP tetramerisation within the CtIP-NTD, we truncated the 
N-terminal sequence that precedes the coiled-coil region (Fig. 1a). SEC-MALS analysis of 
the ensuing region, comprising residues 52 to 145 (CtIP-cNTD), revealed a dimeric structure 
of 23.6 kDa (Fig. 1d), indicating that residues N-terminal to the coiled-coil sequence are 
essential for tetramerisation. We found that, like CtIP-NTD, CtIP-cNTD is almost entirely α-
helical, shows high thermal stability (Supplementary Fig. 2c, d) and contains bound zinc, in 
agreement with a stoichiometry of one zinc atom per CtIP-cNTD dimer (Fig. 1e). Importantly, 
while the double C89A C92A mutant protein no longer bound zinc (Fig. 1e), it retained a 
dimeric structure, indicating that zinc is not required for dimerisation. Nevertheless, the 
double C89A C92A mutation caused an increase in the SEC elution volume of both CtIP-
NTD and CtIP-cNTD, accompanied by reduced thermal stability (Fig. 1b, d and 
Supplementary Fig. 2), suggesting that the zinc-binding motif may act as a rigid strut that 
holds the two coiled-coil segments in an extended conformation. 
To investigate the nature of CtIP tetramerisation, we analysed the N-terminal sequence 
encoded by residues 18-52 (CtIP-nNTD). Remarkably, this short sequence of 35 amino 
acids was sufficient to support tetramerisation, as demonstrated by SEC-MALS analysis of 
CtIP-nNTD, both as a free polypeptide and when fused to a maltose binding protein (MBP) 
tag (Fig. 1f and Supplementary Fig. 1c). We found that this tetrameric structure is α-helical 
in nature (Supplementary Fig. 2e, f) and, in keeping with our other data, does not contain 
bound zinc (Fig. 1e). Collectively, these findings demonstrated that the CtIP N-terminal 
sequence comprising residues 18-52 is necessary and sufficient for CtIP tetramerisation, 
mediated by head-to-head association between CtIP dimers. 
 
Crystal structure of the CtIP tetramerisation motif 
To define the molecular basis for CtIP tetramerisation, we determined the X-ray crystal 
structure of human CtIP-nNTD at a resolution of 1.9 Å (Table 1 and Supplementary Fig. 
1d). Crystallographic analysis showed that the CtIP-nNTD adopts an entirely α-helical 
tetrameric structure, in which two CtIP dimers associate head-to-head through the 
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interdigitating interaction of their splayed N-terminal tails (Fig. 2). In this ‘dimer-of-dimers’ 
assembly, the antiparallel interactions between residues 18-31 in the CtIP-nNTD are 
responsible for tetramerisation, whereas residues 32-52 form parallel dimeric coiled-coils 
(Fig. 2). Each tetramerisation helix is involved in two distinct sets of antiparallel interactions 
with the two N-terminal helices of the opposing CtIP dimer. In one set of interactions, the 
aromatic side chains of tryptophan residues at position 24 in each monomer pack against 
each other in a stacking interaction that is reinforced by reciprocal hydrogen bonding 
between the indole ring nitrogen and the main-chain carbonyl group of the opposing 
tryptophan (Fig. 3a); in the second set, leucine residues 23 and 27 interdigitate in canonical 
antiparallel coiled-coil fashion (Fig. 3b). F20 contributes to both interfaces, by packing 
against the side chain of K28 (Fig. 3a) and by adding one coiled-coil interaction with C30 of 
the antiparallel chain (Fig. 3b). Thus, we conclude that the combination of anti-parallel 
interactions provides a hydrophobic core that buries the side chains of F20 and L27 and 
likely drives tetramer formation. 
The crystal structure further reveals that the C-terminal limit of the CtIP tetrameric interface 
is defined by H31, which packs against F20 of the opposing anti-parallel chain to provide the 
outermost hydrophobic interaction of the tetramer as well as the first dimerisation contact in 
the coiled coil (Fig. 3c). A parallel coiled-coil extends from H31 to the end of CtIP-nNTD, 
with residues V35, L38, V42 and L45 occupying canonical heptad-repeat positions at the 
hydrophobic interface (Fig. 3c). The heptad repeat continues in the CtIP sequence until the 
zinc-binding site defined by C89-X-X-C92 (Supplementary Fig. 1a), indicating that the 
coiled-coil of the CtIP-nNTD is likely to be continuous with the coiled-coil structure of the 
CtIP-cNTD dimer. Taken together, our crystallographic and biophysical data lead to a 
structural model in which the CtIP-NTD undergoes tetramerisation through head-to-head 
‘dimer-of-dimers’ association mediated by the short N-terminal CtIP-nNTD sequence. 
 
L27E mutation blocks CtIP tetramerisation 
Having defined the structural basis of CtIP tetramerisation, we sought to test its physiological 
importance. Thus, we designed a point mutation replacing buried L27 with glutamate (L27E), 
to reverse the chemical nature of the amino acid side chain. The mutation aimed to disrupt 
tetramerisation while preserving the dimeric structure of CtIP, by introducing a charged 
residue in the hydrophobic core of the CtIP tetramerisation motif (Fig. 4a). Importantly, SEC-
MALS analysis confirmed that a CtIP-NTD protein bearing the L27E mutation can only form 
dimeric species, and thereby had an equivalent effect on preventing dimer-of-dimers 
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formation to deletion of amino acids 20-27, which removes the majority of the tetramerisation 
helix (Fig. 4b). 
While we had shown that the L27E mutation does not interfere with CtIP-NTD dimerisation in 
vitro, we wanted to confirm that this is also the case for full-length CtIP in vivo. Thus, we 
stably transfected human U2OS cells with FLAG-tagged versions of full-length wild-type 
CtIP, the single-point mutant L27E and a truncated form of the protein lacking the entire N-
terminal domain, Δ1-140 CtIP (Fig. 4c, top panel). Green-fluorescent protein (GFP)-tagged 
wild-type CtIP was then transiently expressed in these cells and immunoprecipitated. As 
revealed by their co-immunoprecipitation, both wild type and L27E forms of FLAG-CtIP 
interacted with GFP-CtIP, whereas Δ1-140 CtIP did not (Fig. 4c, bottom panel). Thus, the 
L27E mutation does not affect the ability of CtIP to dimerise in cells, in agreement with our 
biophysical data. 
To assess the impact of the L27E mutation in cells, the FLAG-epitope tagged construct of 
either wild type or L27E mutant full-length CtIP protein was transfected transiently into 
human HEK-293 cells. FLAG-CtIP proteins were purified under stringent conditions so as to 
maintain only specific interactions (see Methods) and then subjected to size-exclusion	  
chromatography. The later chromatographic elution of L27E CtIP indicated a substantial 
reduction in size to approximately half the apparent molecular weight of the native molecule 
(Fig. 4d). These findings demonstrated that full-length FLAG-tagged CtIP exists in cells in an 
oligomeric state, and established that oligomerisation is disrupted by the L27E mutation, 
consistent with head-to-head tetramerisation mediated by its N-terminal domain occurring in 
vivo.  
 
CtIP tetramerisation is required for HR and promotes MMEJ 
To test whether the DNA repair function of CtIP was affected by the L27E mutation, we took 
advantage of the fact that we had stably transfected wild-type and mutated CtIP constructs 
in a U2OS cell line containing the Traffic Light Reporter (TLR) system23 integrated into its 
genome. This system consists of an expression cassette containing a truncated eGFP gene 
fused to an mCherry gene that is out-of-frame translationally, and hence not expressed (Fig. 
5a). Transfection of cells with the endonuclease I-SceI generates a DSB in the eGFP gene 
that, when repaired by gene conversion (a form of HR) of an exogenous eGFP template, 
results in the production of a functional eGFP gene and cells acquiring green fluorescence. 
Alternatively, if the DSB is repaired by accurate NHEJ, the cassette is restored and no 
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fluorescence is detected. If, however, mutagenic DSB repair takes place that results in a +2 
translational frameshift, the mCherry reading frame is restored, causing cells to fluoresce red 
(Fig. 5a and Supplementary Fig. 4). The TLR system therefore allows the simultaneous 
measurement of DSB repair in cells by either mutagenic end-joining (mutEJ) or HR via gene 
conversion23. 
To assess the effect of CtIP depletion in the TLR system, we performed the assay in control 
cells not expressing any recombinant form of CtIP and which had been treated with a control 
small-interfering RNA (siRNA) or an siRNA targeting the CtIP coding sequence. While CtIP 
depletion dramatically reduced the ability of cells to perform gene conversion (Fig. 5b, left 
panel), as described previously in other HR reporter systems11, it slightly increased the 
occurrence of mutEJ events (Fig. 5b, right panel), an effect that can be explained by CtIP 
depletion causing an imbalance in the HR/NHEJ/mutEJ ratio23,24. Next, we carried out TLR 
assays with the U2OS-TLR cells that we had engineered to stably express siRNA-resistant 
wild type, L27E or Δ1-140 CtIP proteins (see ‘FLAG’ inputs in Fig. 4c for expression levels of 
each recombinant protein), and which had then been treated with an siRNA to deplete 
endogenous CtIP. As shown in Fig. 5c, whereas wild-type CtIP restored HR proficiency to 
cells depleted of endogenous CtIP protein, both L27E and Δ1-140 CtIP failed to do so, 
essentially behaving as null mutants. (Supplementary Fig. 4i shows that a similar trend 
was observed in regards to decreasing the rate of mutEJ). Taken together, these results 
indicate that dimerisation, which can still take place in the L27E CtIP mutant, is not sufficient 
for CtIP function in gene conversion and support a model in which CtIP ‘dimer-of-dimers’ 
tetramerisation is required for this HR pathway. 
CtIP’s function during DNA repair is not exclusively linked to HR, as cells depleted of CtIP 
also show defects in MMEJ12-15. MMEJ is an alternative end-joining pathway that requires 
limited resection of the DSB, and differs from the classical NHEJ pathway in that it is 
independent of the Ku heterodimer and DNA-PK. In MMEJ, CtIP-mediated limited resection 
is believed to unveil regions of micro-homology that are used to anneal and ligate the broken 
DNA ends25. We used a U2OS-based system (Fig. 5d, left panel; ref. 21) to assess the 
impact of CtIP depletion on MMEJ (Fig. 5d, right panel). We then generated U2OS-MMEJ 
cell lines stably expressing siRNA-resistant FLAG-tagged versions of CtIP and performed 
rescue experiments on cells depleted of endogenous CtIP by siRNA treatment. As shown in 
Figure 5e, and in agreement with previous reports18, wild type CtIP largely complemented 
CtIP deficiency, while Δ1-140 CtIP behaved as a null mutant. Interestingly, two independent 
L27E CtIP clones (Supplementary Fig. 5a) partially rescued the MMEJ deficiency of CtIP-
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depleted cells (Fig. 5e), raising the possibility that CtIP dimers could be functional to some 
degree in this DNA repair pathway. 
 
CtIP tetramerisation promotes DNA-end resection 
CtIP localisation to sites of DNA damage is crucial for its function during DNA repair18,21. To 
test whether CtIP tetramerisation is important for the accumulation of CtIP at damaged sites, 
laser micro-irradiation was performed on U2OS cells stably expressing wild type or L27E 
GFP-CtIP (Supplementary Fig. 5b). Strikingly, the L27E GFP-CtIP mutant protein showed a 
pronounced defect in localising to sites of DNA damage when compared to wild type GFP-
CtIP (Fig. 6a). Similar effects were observed when cells were treated with other DNA-
damaging agents such as hydroxyurea or mitomycin C (Fig. 6b and Supplementary Fig. 
5c; note in Fig. 6b that the L27E mutation did not affect the amount of DNA damage induced 
by such agents, as assessed by induction of the S139-phosphorylated form of histone H2AX 
(γH2AX), a well-established marker of DNA damage26). It has been reported that the N-
terminal part of CtIP, where the tetramerisation motif resides, is important for the constitutive 
interaction of CtIP with the MRN complex18 and that the MRN complex is required for 
localisation of CtIP to DNA-damage sites16. However, the L27E GFP-CtIP mutant protein 
interacts with the components of the MRN complex similarly to wild-type GFP-CtIP (Fig. 6c). 
The inability of CtIP-depleted cells to perform HR is at least in part explained by a defect in 
DNA-end resection11. Resection of a DSB is believed to be essential for all forms of HR, and 
involves the 5'-to-3' nucleolytic degradation of DNA ends to generate single-stranded DNA 
(ssDNA) that is then rapidly bound by the ssDNA-binding protein replication protein A (RPA). 
Subsequently, RPA is replaced by RAD51 to form the nucleoprotein filaments that are 
necessary for strand invasion and completion of gene conversion27. To test whether the HR 
defect we observed in cells expressing the L27E CtIP mutant reflected impaired resection, 
we performed a flow-cytometry assay to detect RPA retention on chromatin28. RPA is 
present at all cell-cycle stages but only becomes chromatin-bound during S phase and when 
ssDNA is exposed under specific circumstances, such as when a DSB is resected. When 
CtIP is depleted, chromatin-bound RPA can still be detected in S-phase cells, but there is a 
dramatic reduction in DNA-damage dependent RPA chromatinization28. The DNA 
topoisomerase I inhibitor camptothecin generates DSBs at DNA replication forks29 that can 
only be repaired by HR and are channelled into the end-resection pathway30. We found that, 
after camptothecin treatment, CtIP-depleted cells exhibited a dramatic reduction of RPA 
chromatinisation that was rescued by expression of wild-type CtIP (Fig. 6d, compare bottom	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panels 1 and 2 showing an increase from 0.5 to 25% RPA-positive cells). Notably, however, 
neither L27E CtIP nor Δ1-140 CtIP rescued the resection defect, despite all cell populations 
containing similar levels of DNA damage as scored by γH2AX immunostaining (Fig. 6d and 
Supplementary Fig. 6). Thus, the HR defect sustained by cells expressing L27E CtIP or Δ1-
140 CtIP correlated with their inability to engage DSBs in DNA-end resection. Collectively, 
these results implied that CtIP dimers are not functional during DNA-end resection and that 
tetramerisation is crucial for CtIP localisation at DNA-damage sites, resection and HR. 
 
DISCUSSION 
We have demonstrated that mutation of CtIP to prevent its tetrameric assembly abrogates 
CtIP function in DNA-end resection and HR. Our crystallographic analysis shows that CtIP 
tetramer formation depends on interlocking interactions between N-terminal ends of 
opposing coiled-coil dimers. Although the crystal structure includes only residues up to 
position 52, the parallel coiled-coil structure is likely to extend to the whole CtIP N-terminal 
region up to residue 145, with the only interruption caused by the zinc-binding motif centred 
on C89 and C92. While the role of zinc coordination by CtIP is unclear (a C89A C92A CtIP 
mutant is proficient in DNA-end resection, our unpublished results), our data suggest that it 
contributes to the conformational rigidity of the coiled-coil region. 
Importantly, our analyses indicate that full-length CtIP undergoes multimeric assembly in 
cells, in a manner consistent with tetramerisation through head-to-head assembly of CtIP 
dimers. Indeed, we find that the apparent molecular weight of full-length CtIP expressed in 
cells is reduced by approximately half upon introduction of the single-point mutation L27E, 
which we established biochemically to block tetrameric assembly while preserving 
dimerisation of the CtIP N-terminal domain. As the L27E mutation behaves as a null CtIP 
mutant in DNA-end resection and HR, this leads us to conclude that the ‘dimer-of-dimers’ 
tetramer represents the functional oligomeric state of CtIP in these processes. 
In agreement with our findings, previous biochemical studies identified a dimeric structure for 
CtIP residues 45-16019,20. It was further reported that sedimentation equilibrium data of a 
CtIP protein spanning residues 22 to 160 could not be interpreted as a single species due to 
non-specific aggregation of the sample19. We note that this construct, while including the 
majority of residues involved in tetramerisation, omits F20. Importantly, we have found that 
mutating F20 to glutamate leads to a mixed population of CtIP-NTD dimers and tetramers 
(Supplementary Fig. 7a), demonstrating that F20 is required for stable tetrameric 
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assembly. In previous studies, deletions of CtIP residues 20-45, 22-45 or the combined 
mutations L27P, K28A, E29A, E34A were also found to block CtIP function in DNA-end 
resection and HR18,21. On the basis of our in vitro and in vivo data, it is now apparent that the 
effects of such mutations can be explained by disruption of CtIP tetramerisation. 
Why is the L27E mutant protein unable to fulfill CtIP’s roles in DNA-end resection and 
repair? It has been recently reported that CtIP possesses endonuclease activity31,32. 
However, CtIP’s function as an endonuclease seems to be dispensable for DNA-end 
resection and, importantly, is not affected by the deletion of the entire N-terminal region of 
CtIP32. Thus, the functional effects we have observed when abrogating CtIP tetramerisation 
cannot reflect a possible negative impact on CtIP’s putative nuclease activity. Perhaps 
surprisingly, we found that although L27E CtIP remains capable of interacting with the MRN 
complex, its accumulation at damage sites is impaired. This observation highlights the 
importance of CtIP’s tetramerisation state for its effective accrual at DNA-damage sites, 
although the precise nature of the underlying molecular mechanism remains unclear. In this 
regard, we note that CtIP function in DNA repair is intimately associated with that of the MRN 
complex. A well-established feature of the MRN complex is its ability to undergo long-range 
self-association mediated by a ‘zinc hook’ in the centre of a 600Å coiled-coil insertion in its 
RAD50 subunit33. These long-range interactions are thought to enable the complex to 
simultaneously engage multiple DNA molecules, a function that appears essential for 
effective HR repair. The molecular model of CtIP emerging from our data presents intriguing 
similarities to the functional architecture of the MRN complex. Given that the CtIP tetrameric 
structure spans 80 Å and each coiled-coil dimer contains up to eleven heptad repeats, a 
linear organisation of the CtIP N-terminal domain may reach up to ~300 Å in length (Fig. 7). 
Thus, a CtIP tetramer might be able to to position its C-terminal domains simultaneously 
onto distinct DNA molecules, where they would cooperate with the MRN complex and other 
factors to promote repair. In agreement with this model, we have found that a region of CtIP 
spanning residues 769 to 897 (C-terminal end of the protein) possesses DNA-binding ability 
(Supplementary Fig. 7b). 
Finally, we note that Sae2, the functional orthologue of CtIP in S. cerevisiae34,35, has also 
been shown to assemble into multimers36, and it was recently reported that post-translational 
modifications of Sae2 regulate its oligomeric state and function37. Although Sae2 is 
considerably smaller than CtIP, its N-terminal region is predicted to be helical, suggesting 
that Sae2 might also adopt a tetrameric structure. This therefore raises the prospect that 
similar regulatory mechanisms could act to switch CtIP between dimeric and tetrameric 
states and thereby control CtIP function in human cells. In this respect, we note that, while 
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we have demonstrated that the ‘dimer-of-dimers’ tetrameric assembly is essential for end 
resection and HR, the results of the MMEJ assay suggest that CtIP dimers could function in 
other cellular processes, such as alternative modes of DNA repair or in gene transcription. 
 
Accession codes. Coordinates and structure factors have been deposited in the Protein 
Data Bank under accession code 4D2H. 
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FIGURE LEGENDS 
Figure 1 CtIP-NTD (amino acids 18-145) exists as a tetramer in solution. (a) Schematic 
diagram of the human CtIP sequence. Based on bioinformatics analysis, the CtIP N-terminal 
domain (NTD) can be divided in a helical (α) N-terminal region (CtIP-nNTD) and a C-terminal 
region (CtIP-cNTD) in which a central C89-X-X-C92 motif is flanked by predicted coiled coils 
(CC). The conserved C-terminal domain (CTD) and the two CDK phosphorylation sites are 
also depicted. (b) Size-exclusion chromatography multi-angle light scattering (SEC-MALS) 
analysis of wild type and C89A/C92A double mutant (DM) recombinant CtIP-NTD. CtIP-NTD 
and CtIP-NTD-DM are tetrameric species of 68.7 kDa and 62.1 kDa, respectively. The light 
scattering (LS) as relative Raleigh ratio and the differential Reflective Index (dRI) are drawn 
as solid and dashed lines, respectively. The values for the fitted molecular masses (Mr) of 
CtIP-NTD and CtIP-NTD-DM are shown as diamond shapes across the respective elution 
peaks. The predicted molecular masses of the monomeric species are shown in brackets 
above each elution peak. (c) Spectrophotometric determination of zinc content using metal 
chelator 4-(2-pyridylazo) resorcinol (PAR), with zinc standards shown in grey. Zinc content 
was estimated as a percentage of the molar protein concentration at 40% and 0.5% for CtIP-
NTD (solid line) and CtIP-NTD-DM (dashed line) respectively. (d) SEC-MALS analysis of 
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CtIP-cNTD and CtIP-cNTD-DM, revealing dimeric species of 23.6 kDa and 21.5 kDa, 
respectively. (e) PAR analysis in which zinc content was estimated at 33%, 0.6% and 0.4% 
for CtIP-cNTD (solid line), CtIP-cNTD-DM (dashed line) and CtIP-nNTD (dotted line) 
respectively. (f) SEC-MALS analysis of CtIP-nNTD reveals a tetrameric species of 17.3 kDa. 
Figure 2 Crystal structure of the tetramerisation domain of human CtIP (CtIP-nNTD; amino 
acids 18-52). The CtIP-nNTD tetramer is formed through the head-to-head association 
between two CtIP dimers, drawn as ribbons and coloured orange and purple. The N- and C-
termini of each CtIP molecule are labelled. The central tetrameric assembly consists of 
interlocking, antiparallel interactions between the two pairs of N-terminal helices comprising 
amino acids 18-31. The C-terminal amino acids 32-52 are part of the region responsible for 
CtIP dimerisation via parallel coiled-coil interactions. Two views of the CtIP-nNTD structure 
are shown, related by 90° rotation around the long axis of the tetramer. 
Figure 3 Details of the homotypic interactions responsible for tetrameric assembly (a, b) and 
dimerisation (c) of CtIP. Each panel shows a ribbon drawing of the CtIP-nNTD (top) and 
side-chain details of CtIP interactions responsible for self-association (bottom). For clarity, 
only the two CtIP chains for which details of side-chain interactions are shown are coloured 
(as in Figure 2), whereas the other two chains are in grey. (a) Antiparallel interactions in the 
tetramerisation motif (residues 18-31) involve side-chain stacking of tryptophan residues at 
position 24 and reciprocal hydrogen bonding (depicted as yellow springs) between their 
indole ring nitrogens and main-chain carbonyl groups. The side chains of interacting 
residues F20 and K28 are also shown. (b) Coiled-coil contacts in the tetramerisation motif 
involve residues F20, L23, L27 and C30 from adjacent pairs of antiparallel helices. (c) The 
coiled-coil dimer is formed between parallel C-terminal sequences (residues 31-52), with 
residues V35 and V42 at the ‘a’ position and residues H31, L38 and L45 at the ‘d’ position of 
the heptad repeat. Histidine residue 31 marks the transition point between the 
tetramerisation motif and the coiled-coil dimer structure. 
Figure 4 CtIP mutation L27E abrogates tetramer assembly while preserving coiled-coil 
dimerisation. (a) L27E introduces a charged residue in the hydrophobic core of the tetramer. 
CtIP is drawn as ribbon; tetramerisation region is coloured red, the rest of the chain in 
yellow. The side chain of L27 is shown in green as stick drawing. (b) SEC-MALS analysis 
revealing that CtIP-NTD L27E and Δ20-27 proteins are dimeric species. The LS as relative 
Raleigh ratio, the dRI and the Mr are drawn as in Figure 1. The predicted molecular masses 
of the monomeric species are shown in brackets above each elution peak. (c) Top panel: 
diagram of the FLAG-tagged CtIP derivatives used in the immunoprecipitation (IP) 
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experiments. The CtIP-NTD region is coloured as in panel a. Bottom panel: western blot 
showing co-immunoprecipitation of wild-type (WT) GFP-CtIP with the WT and L27E versions 
of FLAG-CtIP, but not with CtIP Δ1-140. Control IP was performed with cells that express 
WT FLAG-CtIP transfected with a GFP-expressing plasmid. (d) Western blot of the fractions 
from a gel filtration experiment shows that FLAG-tagged WT CtIP (upper panel, peak at 
fraction 3) elutes earlier than the corresponding L27E mutant (lower panel, peak at fraction 
7). Inputs are shown in the first lane. The elution volume of each fraction, the elution position 
for size markers ferritin (440 kDa) and aldolase (58 kDa) and the estimated sizes of WT 
FLAG-CtIP and L27E FLAG-CtIP are also shown. Uncropped images for all western blot 
data can be seen in Supplementary Fig. 8. 
Figure 5 CtIP mutation L27E impairs HR and, to a lesser extent, MMEJ. (a) Schematic of 
the Traffic Light Reporter (TLR) system (adapted from ref. 23; see also Supplementary Fig. 
4). (b) CtIP depletion reduces HR efficiency (left panel) and slightly increases the rate of 
mutagenic end-joining (right panel) in the TLR system. (c) Only expression of wild-type (WT) 
FLAG-tagged CtIP rescues the HR deficiency caused by endogenous CtIP depletion. All 
values are normalised to cells transfected with control siRNA. (d) Left panel: schematic of 
the MMEJ system (adapted from ref. 21). Right panel: CtIP depletion impairs MMEJ. (e) 
L27E FLAG-CtIP is not completely defective in MMEJ. EV: empty vector. All quantifications 
are averages of n = 3 biological replicates (independent siRNA transfections). Error bars are 
± SEM. 
Figure 6 CtIP mutation L27E impairs CtIP accumulation at DNA-damage sites and DNA-end 
resection. (a) L27E GFP-CtIP shows defective accumulation at laser-induced DNA-damage 
sites. Samples were fixed 30 min after irradiation. Cells were stained with γH2AX (to detect 
damaged cells) and cyclin A (to identify cells in S and G2 phases of the cell cycle) 
antibodies. Note that CtIP is not recruited to DNA-damage sites in G1 cells. (b) L27E GFP-
CtIP also shows defective accumulation in other DNA-damaging conditions. Cells were left 
untreated or treated for 24 h with 1 mM hydroxyurea (HU) or 120 ng/ml mytomycin C (MMC). 
Quantification of γH2AX-positive cells is shown as control for DNA damage (see also 
Supplementary Fig. 5c) (c) L27E GFP-CtIP interacts with the MRN complex. (d) Only 
expression of wild-type (WT) FLAG-tagged CtIP rescues the resection defect caused by 
endogenous CtIP depletion. Left panel: dot plots representing the intensity of the signal of 
RPA staining (y axis) against the DNA content (x axis). Quantification gates were 
established in untreated samples (Supplementary Fig. 6). Right panel: quantification of RPA-
positive cells. All values are normalised to the percentage of γH2AX-positive cells and to 
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cells transfected with control siRNA (Supplementary Fig. 6). EV: empty vector. All 
quantifications are averages of n = 3 biological replicates (independent siRNA transfections). 
Error bars are ± SEM. Uncropped images for all western blot data can be seen in 
Supplementary Fig. 8. 
Figure 7 Model for the functional architecture of human CtIP. The central tetrameric 
assembly of the NTD holds CtIP dimers in a head-to-head orientation. The two ends of this 
central tetramer extend into coiled-coil structures that define the CtIP dimers. Each dimer 
comprises two coiled-coil regions flanking a central zinc-binding site, in which one zinc ion is 
co-ordinated by C89 and C92 of the two CtIP chains. The CtIP-NTD may span a total 
distance of up to 300 Å.  
 
ONLINE METHODS 
Recombinant protein expression and purification 
Sequences corresponding to human CtIP residues 1-145, 18-145, 18-52, 52-145 and 769-
897, including point mutants L27E, F20E, C89A/C92A and Δ20-27, were cloned into 
pMAT11 vectors38 for expression as N-terminal His6-MBP fusion proteins. Constructs were 
expressed in BL21(DE3)Rosetta2 cells (Novagen®), in 2xYT media, induced with 0.5 mM 
IPTG for 16 hours at 20°C. Fusion proteins were purified from clarified lysate through 
consecutive Ni-NTA (Qiagen) and amylose (NEB) affinity chromatography. Affinity tags were 
removed by incubation with TEV protease (Invitrogen) and reverse binding to Ni-NTA resin. 
Further purification was achieved through anion exchange chromatography (Resource Q: 
GE Healthcare) and size-exclusion chromatography (HiLoadTM 16/600 Superdex 200: GE 
Healthcare) in 20 mM Tris pH 8.0, 150 mM NaCl, 2 mM DTT. Protein samples were 
concentrated to 10 mg/ml using Amicon Ultra® 10,000 MWCO centrifugal filter units 
(Millipore), and were stored at -80˚C following flash-freezing in liquid nitrogen. 
 
Circular dichroism (CD) spectroscopy 
Far-UV CD spectroscopy data were collected on an Aviv 410 spectropolarimeter (Biophysics 
facility, Department of Biochemistry, University of Cambridge). CtIP samples were analysed 
at 0.15 mg/ml, in 10mM Na2HPO4/ NaH2PO4 pH 7.5, using a 1 mm path-length quartz 
cuvette (Hellma). CD spectra were recorded at 0.5 nm intervals between 260 and 185 nm 
(with 1 nm slit width and 1 s averaging time), at 5°C. Mean residue ellipticity ([θ]) was 
calculated from smoothed corrected raw data averaged across three recordings, and 
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deconvolution was performed using the CDSSTR algorithm of the Dichroweb server 
(http://dichroweb.cryst.bbk.ac.uk)39,40. CD thermal denaturation data were recorded at 222 
nm, at 1°C intervals between 5 and 95°C (1°C per minute ramping rate, with 30 s incubation 
time). Raw data were converted to mean residue ellipticity ([θ222]). 
 
Size-exclusion chromatography multi-angle light scattering (SEC-MALS) 
The absolute molecular masses of recombinant CtIP protein samples were determined by 
size-exclusion chromatography multi-angle light scattering (SEC-MALS). 100 µl protein 
samples (at approximately 2 mg/ml) were loaded onto a Superdex™ 200 10/300 GL size 
exclusion chromatography column (GE Healthcare) in 20 mM Tris pH 8.0, 150 mM NaCl, 2 
mM DTT, at 0.5 ml/min using an ÄKTA™ Purifier (GE Healthcare). The column output was 
fed into a DAWN® HELEOS™ II MALS detector (Wyatt Technology), followed by an 
Optilab® T-rEX™ differential refractometer (Wyatt Technology). Light scattering and 
differential refractive index data were collected and analysed using ASTRA® 6 software 
(Wyatt Technology). Molecular masses and estimated errors were calculated across 
individual eluted peaks by extrapolation from Zimm plots using a dn/dc value of 0.1850 ml/g. 
SEC-MALS data are presented with light scattering (LS) and differential refractive index (dRI) 
plotted alongside fitted molecular weights (MW).  
 
Spectrophotometric analysis of zinc content 
A method for the spectrophotometric determination of zinc content was adapted from the 
published protocol22. CtIP recombinant protein samples at 0.5-0.1 mg/ml were digested with 
0.6 µg/µl proteinase K (NEB) at 60°C for 1 hour. For each digested protein sample, in 
addition to standard solutions containing 0-100 µM zinc acetate, 10 µl of supernatant was 
added to 80 µl of 50 µM 4-(2-pyridylazo)-resorcinol (PAR) in 20 mM Tris pH 8.0, 300 mM 
NaCl, incubated for 5 minutes at room temperature, and UV absorbance spectra recorded 
between 600 and 300 nm (Varian Cary 50 spectrophotometer). Zinc concentrations were 
estimated by comparison of A492nm/(A414nm+A492nm) with lines of best fit obtained from analysis 
of 0-100 µM zinc acetate solutions. Protein concentrations were determined by UV 
spectrophotometry, with extinction coefficients and molecular weights calculated by 
ProtParam (http://web.expasy.org/protparam/). 
 
Protein crystallisation and X-ray structure solution 
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Protein crystals were obtained through hanging drop vapour diffusion in which CtIP-nNTD at 
4.7 mg/ml was mixed with equal volumes of reservoir solution (200 mM lithium sulphate, 100 
mM sodium acetate pH 3.6, 32% (v/v) PEG 400) and equilibrated for 7-10 days. Suitable 
crystals were incubated in cryoprotectant (20 mM Tris pH 8.0, 150 mM sodium chloride, 200 
mM lithium sulphate, 100 mM sodium acetate pH 3.6, 32% (v/v) PEG 400, 20% (v/v) 
glycerol) and frozen in liquid nitrogen. X-ray diffraction data were collected at 1.03970 Å 
wavelength as 1000 contiguous frames with 0.2 second exposure and 0.2 degrees of 
oscillation on a Pilatus 6M detector at beamline PROXIMA1 of the Soleil synchrotron in 
Paris, France. The data were indexed, integrated and scaled in XDS41, and merged using 
Aimless (CCP4 software package)42. The data could be indexed equally well in a monoclinic 
or orthorhombic lattice, and the crystal was initially assigned to orthorhombic space group 
P212121, with cell dimensions: a=36 Å, b=38 Å, c= 98 Å and four predicted CtIP molecules in 
the asymmetric unit. The structure was solved with the molecular replacement method in 
Phaser43, using as search model a homology-model helical template spanning amino acids 
18-52 of human CtIP, built by fold-recognition server PHYRE44. Phaser placed four copies of 
the helical template, arranged as an antiparallel dimer of two dimeric parallel coiled-coils. 
The tetrameric assembly was refined to 2.1 Å resolution with Phenix45 and Buster46, using 
Coot47 for manual model building. Reanalysis of the data processing during refinement 
highlighted the fact that the merging statistics were better in the case of monoclinic 
symmetry (P212121: Rmerge=0.180, Rmeas=0.195, Rpim=0.073; P21: Rmerge=0.056, Rmeas =0.065; 
Rpim=0.034), and therefore refinement was continued in space group P21, with two copies of 
the tetramer in the asymmetric unit. The final crystallographic model was refined to R and 
Rfree values of 0.237 and 0.251 respectively, at a resolution of 1.9 Å, with all residues of the 
asymmetric unit in the favoured region of the Ramachandran plot.  
 
Cell lines, culture conditions, drugs and transfections 
Human U2OS and HEK-293T cells were grown in DMEM supplemented with 10% FBS, 
penicillin, streptomycin and glutamine. U2OS-TLR cells were selected in the presence of 2 
μg/ml puromycin. U2OS-TLR cells stably transfected with FLAG-tagged versions of CtIP 
were grown in the presence of 0.5 μg/ml puromycin and 0.5 mg/ml geneticin. U2OS-MMEJ 
cells were described previously21. U2OS-MMEJ cells stably transfected with FLAG-tagged 
versions of CtIP were grown in the presence of 150 μg/ml hygromycin and 0.25 mg/ml 
geneticin. U2OS cells stably transfected with GFP-tagged versions of CtIP were grown in the 
presence of 0.5 mg/ml geneticin. Camptothecin, hydroxyurea and mytomycin C were from 
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Sigma. Plasmid transfections were performed with Fugene HD (Promega) following 
manufacturer’s conditions. siRNA transfections were performed with Lipofectamine RNAiMax 
(Life Technologies) using manufacturer’s conditions. 
 
Plasmids, siRNAs and antibodies 
3xFLAG-CtIP vector was generated by replacing eGFP of GFP-CtIP11 with the 3xFLAG 
linker at the NheI and SalI sites. L27E was introduced in 3xFLAG-CtIP or GFP-CtIP by site-
directed mutagenesis with Pfu Polymerase AD (Agilent Technologies). Δ1-140 3xFLAG-CtIP 
was generated by PCR with the 3xFLAG-CtIP plasmid as template. Antibodies for western 
blotting were: anti-FLAG M2 (Sigma F3165, 1:1000 dilution), anti-GFP 7.1/13.1 (Roche 
11814460001, 1:1000), anti-RAD50 13B3 (Abcam ab89, 1:1000; see manufacturer’s web 
page for validation details), anti-MRE11 (Abcam ab33125, 1:10000; see manufacturer’s web 
page for validation details), anti-NBS1 1D7 (Abcam ab7860, 1:1000; see manufacturer’s web 
page for validation details). siRNA sequences: Control siRNA (Luciferase 5'-
CGUACGCGGAAUACUUCGA-3'), CtIP siRNA (5'-GCUAAAACAGGAACGAAUC-3'). All 
CtIP constructs are siRNA-resistant11. 
 
Gel filtration 
Nuclear extracts from HEK-293T cells transiently transfected with plasmids expressing wild 
type or L27E versions of FLAG-CtIP were prepared as described previously48. NaCl 
concentration in extracts was adjusted to 300 mM and FLAG-tagged proteins were isolated 
by EZview Red anti-FLAG M2 Affinity gel (Sigma). Anti-FLAG beads were washed three 
times with lysis buffer containing 300 mM NaCl. Following elution with 3xFLAG peptide 
(Sigma) proteins were fractionated on a Superdex 75 HR 10/30 column (GE Healthcare). 
Relative molecular weights of the FLAG-CtIP protein complexes were calculated based on 
the elution profiles of the calibration standards (GE Healthcare), which were as follows: 
thyroglobulin (669 kDa), ferritin (440 kDa), aldolase (158 kDa), conalbumin (75 kDa), 
ovalbumin (44 kDa). 
 
Immunoprecipitations (IPs) 
For CtIP dimer analyses, U2OS-TLR cells expressing versions of 3xFLAG-CtIP were 
transfected with a wild-type form of GFP-CtIP. 48 h after transfection, cells were scraped off 
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15 cm plates, pelleted and resuspended in 0.5 ml of lysis buffer (20 mM Tris-HCl pH 7.5, 40 
mM NaCl, 2 mM MgCl2, 10% glycerol, 0.5% NP-40, EDTA-free protease inhibitors (Roche), 
10 mM N-ethylmaleimide (Sigma-Aldrich), phosphatase inhibitor cocktail (42 μg/ml NaF, 
0.22 mg/ml beta-glycerophosphate, 37 μg/ml Na3VO4, 2.2 mg/ml sodium pyrophosphate)) 
containing 100 U of benzonase (Merck). After a 5 min incubation at room temperature, 50 μl 
of 5 M NaCl were added to the mix and tubes were left on ice for 15 min. Extracts were 
pelleted at 15 000 rpm at 4 °C for 45 min. Supernatants were recovered and diluted with 0.5 
ml of lysis buffer with no benzonase. 1 mg of protein extract and 10 μl of GFP-Trap 
(ChromoTek) bead slurry were used per IP. IPs were incubated with rotation for 1.5 h at 4 
°C. Beads were washed 5x with lysis buffer, changing tubes after the first wash. 
Immunoprecipitated proteins were eluted from the beads using 1x Lämmli buffer and boiling 
for 5 min. Samples were run in a 6% SDS-PAGE gel. For co-immunoprecipitations with 
known interactors, HEK-293T cells were transiently transfected with wild type or L27E GFP-
CtIP, or the plasmid backbone expressing GFP only as a control. The rest was performed as 
described above. Samples were analysed in a 6-18% SDS-PAGE gel. 
 
Generation of U2OS-TLR cells 
Viral particles containing pCVL Traffic Light Reporter 1.1 (Sce target) Ef1a Puro23 were 
generated by transfection of HEK-293T cells together with pMD2.G and psPAX2 (Addgene). 
Media containing the viral particles were collected 48 h after transfection, filtered and used to 
replace the medium of U2OS cells seeded the previous day. 48 h after media exchange, 2 
μg/ml puromycin was added to select for integration events. Several clones were picked 10-
15 days after starting selection and tested by transfection of pRRL sEF1a 
HA.NLS.Sce(opt).T2A.IFP (I-SceI nuclease plasmid) and pRRL SFFV 
d20GFP.T2A.mTagBFP Donor23. One of the clones displaying no background mCherry 
fluorescence in non-transfected cells and non-coincidental eGFP and mCherry fluorescence 
in cells transfected with both IFP-nuclease and BFP-Donor (indicative of a single integration 
of the TLR cassette) was selected for further experimentation. 
 
TLR assay 
U2OS-TLR cells were stably transfected with empty vector or forms of 3xFLAG-CtIP. Clones 
with similar expression levels of 3xFLAG-CtIP were selected (Fig. 4c). 350 000 cells were 
seeded in 6-cm dishes and transfected with control siRNA (siLuciferase) or siRNA targeting 
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CtIP. 6 h after transfection, plates were washed and cells were transfected with 2 μg of BFP-
Donor and 3 μg of IFP-nuclease. 72 h after siRNA transfection, cells were collected by 
trypsinization, resuspended in 300 μl of 1x PBS + 1 mg/ml BSA and immediately analyzed in 
an LSR-Fortessa Cell Analyzer (BD Biosciences) (Supplementary Fig. 4b). Alternatively, 
cells were fixed for 20 min at room temperature in 2% paraformaldehyde in 1x PBS, washed, 
resuspended in 300 μl of 1x PBS + 1 mg/ml BSA and kept at 4 °C for posterior analysis. 
Flow cytometry analysis was performed by exciting BFP with a 405 nm laser and emissions 
collected via a 450/50 filter. IFP was excited with a 635 nm laser and emissions collected via 
a 670/30 filter. eGFP was excited with a 488 nm laser and emissions collected via a 530/30 
filter. mCherry was excited with a 561 nm laser and emissions collected via a 610/20 filter. 
For a representative example of the gating strategy, see Supplementary Fig. 4. 
Background signal was subtracted for each sample and the intensity of the BFP signal was 
used to normalise the percentages of eGFP-positive cells, as the efficiency of homologous 
recombination increases with increasing amounts of transfected BFP-Donor23. Data analysis 
was performed using FlowJo X (Tree Star). 
 
MMEJ assay 
U2OS-MMEJ cells21 were stably transfected with empty vector or forms of 3xFLAG-CtIP. 
Clones with similar expression levels of 3xFLAG-CtIP were selected (Supplementary Fig. 
5a). 350 000 cells were seeded in 6-cm dishes and transfected with control siRNA 
(siLuciferase) or siRNA targeting CtIP. 6 h after transfection, plates were washed and cells 
were transfected with 3 μg of pCBASce, a vector that expresses I-SceI nuclease49. 72 h after 
siRNA transfection, cells were collected by trypsinization, resuspended in 300 μl of 1x PBS + 
1 mg/ml BSA and immediately analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences). 
Flow cytometry analysis was performed by exciting eGFP with a 488 nm laser and emissions 
collected via a 530/30 filter. Data analysis was performed using FlowJo X (Tree Star). 
 
Laser micro-irradiation and immunofluorescence 
For generation of localized damage in cellular DNA by exposure to a UV-A laser beam50,51, 
cells were plated on glass-bottomed dishes (Willco-Wells) and presensitized with 10 µM 
BrdU (Sigma-Aldrich) in phenol red-free medium (Invitrogen) for 24 h at 37°C. Laser micro-
irradiation was performed by using a FluoView 1000 confocal microscope (Olympus) 
equipped with a 37°C heating stage (Ibidi) and a 405-nm laser diode (6 mW) focused 
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through a 603 UPlanSApo/1.35 oil objective to yield a spot size of 0.5–1 mm. The time of cell 
exposure to the laser beam was ~250 msec (fast scanning mode). Laser settings (0.4-mW 
output, 50 scans) were chosen to generate a detectable damage response restricted to the 
laser path in a presensitization-dependent manner without noticeable cytotoxicity. Imaging 
was done on the same microscope by using the objective and software as described above. 
30 min after irradiation, cells were washed three times with PBS followed by fixation with 2% 
paraformaldehyde (w/v) in PBS for 10 min. Following three washes with PBS, Cells were 
permeabilised in 0.5% Triton X-100 in PBS for 5 min. Following three washes with PBS, cells 
were co-stained with primary antibodies against γH2AX (Cell Signaling 2577, 1:500 dilution; 
see manufacturer’s web page for validation details) and cyclin A H432 (Santa Cruz sc-751, 
1:500; see manufacturer’s web page for validation details) in 5% FBS in PBS for 1 h at RT. 
Following three washes with PBS, cells were stained with goat anti-rabbit Alexa Fluor 594 
secondary antibody (Molecular Probes, 1:1000) in 5% FBS in PBS for 30 min at RT. 
 
Quantification of GFP-CtIP accumulation in damaged cells 
U2OS cells stably expressing wild type or L27E mutant GFP-CtIP were left untreated or 
treated for 24 h with 1 mM hydroxyurea or 120 ng/ml mytomycin C. After treatment cells 
were trypsinised, collected and resuspended in extraction buffer (25 mM HEPES pH 7.4, 50 
mM NaCl, 1 mM EDTA, 3 mM MgCl2, 300 mM sucrose, 0.5% Triton X-100, protease 
inhibitors) for 5 min on ice. After washing with 1xPBS + 1 mg/ml BSA (PBS-B), cells were 
fixed for 20 min at room temperature in 2% paraformaldehyde in 1xPBS. After washing with 
PBS-B, cells were incubated with antibodies against γH2AX (Cell Signalling 2577, 1:200). 
Antibody detection was by incubating cells with goat anti-rabbit Alexa Fluor 594 (Molecular 
probes, 1:1000). DNA was stained with 4',6-diamidino-2-phenylindole (DAPI). Samples were 
analyzed in an LSR-Fortessa Cell Analyzer (BD Biosciences). Data analysis was performed 
using FlowJo X (Tree Star). 
 
DNA-end resection assay 
Sample preparation was as described previously28. Briefly, U2OS-TLR cells expressing 
forms of 3xFLAG-CtIP were transfected with control siRNA (siLuciferase) or siRNA targeting 
CtIP. 48 h after transfection, cells were left untreated or treated with 1 μM camptothecin for 1 
h. After permeabilization and fixation, cells were incubated with antibodies against an RPA 
subunit (RPA2 9H8; Abcam ab2175 1:500 dilution; see manufacturer’s web page for 
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validation details) and γH2AX (Cell Signalling 2577, 1:200). Antibody detection was by 
incubating cells with goat anti-mouse Alexa Fluor 488 (Molecular probes, 1:1000) and goat 
anti-rabbit Alexa Fluor 594 (Molecular probes, 1:1000). DNA was stained with 4',6-diamidino-
2-phenylindole (DAPI). Samples were analyzed in an LSR-Fortessa Cell Analyzer (BD 
Biosciences). Data analysis was performed using FlowJo X (Tree Star). 
 
Electrophoretic mobility shift assay 
CtIP constructs for the NTD and CTD were incubated with 1μM fluorescein-labelled 200bp 
double-stranded DNA at concentrations: 0, 0.5, 1.0, 2.0 , 5.0 and 10μM in 20 mM Tris pH 
8.0, 150mM NaCl for 60 minutes in darkness at room temperature. To the 10μl reaction 
volume, 2μl of gel loading buffer comprising of 250mM Tris pH 8.0, 40% glycerol and 
bromophenol blue was added and samples were analysed by electrophoresis on a 1.5% 
(wt/vol) agarose gel (Ultra Pure Invitrogen) in 0.5xTB buffer at 25V for 2.5h at 4°C. DNA was 
visualised in a Gel Doc-It visualisation system using UV light. 
 
 
SUPPLEMENTARY FIGURE LEGENDS 
Supplementary Figure 1. Sequence alignment of the CtIP N-terminal domain, summary of 
recombinant protein constructs, SEC-MALS analysis of MBP-CtIP-nNTD and details of the 
2Fo - Fc electron density map of CtIP-NTD. (a) Multiple sequence alignment, including the 
predicted secondary structure (red rods indicate regions of predicted α-helix) and coiled-coil 
regions; the probability of coiled-coil formation is indicated by ‘-’ (<50%), ‘c’ (50-90%) or ‘C’ 
(>90%). Protein sequence analysis was performed with the Jalview suite of bioinformatics 
tools (www.jalview.org). Hs: Homo sapiens, Mm: Mus musculus, Ec: Equus caballus, Oc: 
Oryctolagus cuniculus, Gg: Gallus gallus, Xl: Xenopus laevis, Dr: Danio rerio. (b) SDS-PAGE 
analysis of purified recombinant CtIP protein samples: NTD, NTD-DM (C89A C92A), nNTD, 
cNTD, cNTD-DM (C89A C92A) and CTD visualised by Coomassie staining. (c) MBP-CtIP-
nNTD eluted in a single peak corresponding to a molecular weight of 187 kDa; its theoretical 
tetramer size is 197 kDa. For comparison, free MBP eluted in a single peak of 44.5 kDa, 
corresponding to its theoretical monomer size of 44.7 kDa. The light scattering (LS) as 
relative Raleigh ratio and the differential Reflective Index (dRI) are drawn as solid and 
dashed lines, respectively. The value for the fitted molecular mass (Mr) of MBP-CtIP-nNTD is 
shown as diamond shapes across its elution peak. The predicted molecular masses of 
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monomeric MBP-CtIP-nNTD and free MBP are shown in brackets above the respective 
elution peak. (d) Details of the 2Fo - Fc electron density map, contoured at 1.2 rmsd, 
superimposed on the refined crystallographic model of CtIP-NTD. The figure shows the map 
in the vicinity of amino acid W24. The map is shown as thin mesh in light purple, the protein 
atoms are shown in ball-and-stick representation and coloured according to chemical 
identity. The figure was prepared in Coot47. 
Supplementary Figure 2. Circular dichroism (CD) analysis of CtIP N-terminal domain 
constructs. (a, c, e) Far UV CD spectra recorded between 260 and 185 nm, in mean residue 
ellipticity, MRE ([θ]) (1000x deg.cm2.dmol-1.residue-1), with α-helical content calculated 
through deconvolution using the CDSSTR algorithm with normalised root-mean-square 
deviation values (nrmsd) as shown. (b, d, f) CD thermal denaturation data recorded between 
5 and 95°C, in mean residue ellipticity at 222 nm ([θ]222). (a) CD spectra and (b) thermal 
denaturation of CtIP-NTD (solid line) and CtIP-NTD-DM (dashed line). (c) CD spectra and 
(d) thermal denaturation of CtIP-cNTD (solid line) and CtIP-cNTD-DM (dashed line). (e) CD 
spectra and (f) thermal denaturation of CtIP-nNTD. 
Supplementary Figure 3. Microbeam proton induced X-ray emission (microPIXE) analysis 
of the CtIP N-terminal domain in buffer containing KBr. (a) Rutherford backscattering (RBS) 
spectrum and (b) PIXE spectrum with raw data shown as black dots and the modelling fitting 
as red lines. (c) Zinc was detected at a mean atomic ratio to sulphur of 0.095, which given 
the presence of three methionine and three cysteine residues per chain, corresponds to a 
CtIP-NTD:Zn2+ ratio of 1.8:1. 
Supplementary Figure 4. Experimental procedure and gating scheme for the Traffic Light 
Reporter (TLR) system. (a) TLR cells are not fluorescent due to the fact that the TLR 
cassette contains an in-frame truncated version of the eGFP gene and full-length mCherry is 
out of frame. When TLR cells are transfected with an I-SceI nuclease encoded in a plasmid 
also expressing an infrared fluorescent protein (IFP) and an exogenous donor template 
containing the missing part of eGFP that also expresses a blue fluorescent protein (BFP), 
the different repair outcomes will give different fluorescent cells. If the double-strand break 
(DSB) is repaired by gene conversion (homologous recombination), eGFP is restored and 
the cells fluoresce in green. If the DSB is repaired by mutagenic end joining causing a +2 
frameshift, mCherry gets in frame and its expression yields red fluorescence. The T2A “dis-
linker” between eGFP and mCherry allows the downstream-encoded mCherry to escape 
degradation of the misfolded protein encoded in the +3 reading frame of eGFP23. (b) 
Experimental outline of the TLR assay. (c-h) Gating scheme for a TLR assay. (c) 
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Discrimination of cells over debris using a forward scatter vs. side scatter plot (areas). (d) 
Discrimination of cell singlets over doublets using a forward scatter (area) vs. side scatter 
(width) plot. (e) Selection of events for quantification. Dot plot showing the intensity of BFP 
(donor; x axis) vs. intensity of IFP (nuclease; y axis). Cells with negative staining for both 
BFP and IFP are depicted in (f) to show the absence of eGFP or mCherry fluorescence in 
non-transfected cells, and to establish quantification gates. Cells counted positive for both 
BFP and IFP (that is, transfected with both the donor and the nuclease) are represented in 
(g), where quantification gates are the same as the ones established in (f). At least 10,000 
events were analysed in the double-positive population. (h) Due to the fact that the amount 
of donor transfected in the cells affects the outcome of the assay23, the intensity of the BFP 
signal in the double-positive cells (geometric mean of BFP signal in ‘BFP+ IFP+’ cells) was 
calculated for normalisation purposes (see Methods). (i) Mutagenic end-joining (mutEJ) rates 
in the TLR-CtIP complementation system. Only expression of the wild-type version of FLAG-
CtIP reduced the rate of mutEJ to values similar to the control (cells transfected with control 
siRNA). EV: empty vector. All quantifications are shown as the average of three independent 
experiments. Error bars are ± SEM. 
Supplementary Figure 5. CtIP expression levels in the different stable cell lines generated 
and FACS quantification of GFP-CtIP accumulation on damaged cells. (a) CtIP expression 
levels in the different U2OS-MMEJ FLAG-CtIP clones. Samples were collected 48 h after 
siRNA transfection. CtIP antibody was a gift from R. Baer. PARP-1 antibody (Cell Signalling) 
was used as loading control. (b) GFP-CtIP expression levels in the U2OS stable cell lines. 
RPA34-20 (Merck) antibody was used as loading control. (c) A representative complete 
dataset for quantification of GFP-CtIP accumulation on damaged cells. Dot plots 
representing, for each dataset, gating and quantification (in the y axis) of the GFP-positive 
cells (top panels) and the γH2AX-positive cells (bottom panels) taking into account their 
DNA content (x axis). Quantification gates were always established using the untreated 
samples of each dataset. At least 10,000 events were analysed per sample. 
Supplementary Figure 6. A representative complete dataset for the DNA-end resection 
assay. Dot plots representing, for each dataset, gating and quantification (in the y axis) of 
the RPA-positive cells (top panels) and the γH2AX-positive cells (bottom panels) taking into 
account their DNA content (x axis). Quantification gates were always established using the 
untreated samples of each dataset and were defined as to avoid quantification of RPA 
chromatinisation due to DNA replication. Note that as camptothecin (CPT) only causes DNA 
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double-strand breaks in S-phase cells, both RPA- and γH2AX-positive cells only appear in 
that cell cycle stage. At least 10,000 events were analysed per sample. 
Supplementary Figure 7. (a) SEC-MALS analysis of F20E CtIP-NTD. F20E CtIP-NTD 
forms two distinct species of 62.3 kDa and 33.2 kDa, corresponding to its theoretical 
tetramer and dimer sizes of 63.2 kDa and 31.6 kDa, respectively. The light scattering (LS) as 
relative Raleigh ratio and the differential Reflective Index (dRI) are drawn as solid and 
dashed lines, respectively. The values for the fitted molecular masses (Mr) of dimeric and 
tetrameric F20E CtIP-NTD are shown as diamond shapes across the respective elution 
peaks. The predicted molecular mass of monomeric F20E CtIP-nNTD is shown in brackets 
above the elution peaks. (b) Electrophoretic mobility shift assay measuring the ability of CtIP 
NTD and CTD regions to interact with linear, double-stranded DNA. In the experiment, 
increasing amounts (0, 0.5, 1.0, 2.0, 5.0 and 10µM) of the CtIP protein were incubated with a 
1µM sample of 5’ fluorescein-labelled 200bp double-stranded DNA. After incubation, each 
sample was resolved by electrophoresis on agarose gel and visualised under UV light. 
Supplementary Figure 8. Uncropped images for all western blot data. (a) Co-
immunoprecipitations shown in Figure 4c. (b) Gel filtration experiment shown in Figure 4d. 
(c) Co-immunoprecipitations shown in Figure 6c. 
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Table 1  Data collection and refinement statistics 
 
 CtIP-NTD (amino acids 18-52) 
Data collection  
Space group P21 
Cell dimensions    
    a, b, c (Å) 35.97, 37.91, 97.79 
    a, b, g  (°)  90.00, 90.02, 90.00 
Resolution (Å) 28.98 - 1.90 (1.94 - 1.90) 
Rmerge 0.063 (0.919) 
Rmeas 0.074 (1.074) 
Rpim 0.038 (0.547) 
I / sI 10.2 (1.6) 
CC(1/2) 0.998 (0.770) 
Completeness (%) 99.5 (99.5) 
Multiplicity 3.6 (3.6) 
  
Refinement  
Resolution (Å) 28.97 - 1.90 
No. reflections 20969 
Rxpcta/ Rfreeb 0.212/0.251 
No. atoms 2474 
    Protein 2267 
    Ligand/ion 70 
    Water 137 
B-factors 49.2 
    Protein 47.4 
    Ligand/ion 103.4 
    Water 52.5 
R.m.s. deviations  
    Bond lengths (Å) 0.012 
    Bond angles (°) 1.34 
Values in parentheses are for highest-resolution shell. 
a Rxpct = 
€ 
||Fobs | − |Fxpct ||
hkl
∑
|Fobs |
hkl∑
, where Fobs and Fxpct are the observed structure-factor amplitude 
and the expectation of the model structure factor amplitude, respectively46. 
b Rfree equals Rxpct of the test set (5% of the data that were excluded from refinement). 
 
a b
fe
Figure 1
A
bs
or
ba
nc
e
300
0
0.6
0.4
0.2
0.8
350 400 450 500 550 600
Wavelength (nm)
CtIP-NTD
CtIP-NTD-DM
(40% Zn2+)
(0.5% Zn2+)
Zn2+
standards
(0-100 + M)
89C-X-X-C92
CC CC_CtIP-NTD
18-145
14518
CtIP-NTD
(15.9 kDa)
Mr
LS
dRI
CtIP-NTD-DM
(15.8 kDa)
68.7 kDa
62.1 kDa
0
M
ol
ec
ul
ar
 m
as
s,
 M
r
(k
D
a)
40
60
100
20
0
0.5
R
elative R
ayleigh ratio &
 dR
I
1.0
10.0 10.5 11.0
Elution volume (ml)
80
Human CtIP
8971 NTD CTD
Thr847Ser327
CDK
CtIP-cNTD
(11.8 kDa)
LS
dRI
CtIP-cNTD-DM
(11.7 kDa)
23.6 kDa
21.5 kDa
0
M
ol
ec
ul
ar
 m
as
s,
 M
r
(k
D
a)
20
30
40
10
0
0.5
R
elative R
ayleigh ratio &
 dR
I
1.0
13.5 14.0 14.5
Elution volume (ml)
15.0
CtIP-nNTD
 
(4.6 kDa)
LS
dRI
17.3 kDa
0
M
ol
ec
ul
ar
 m
as
s,
 M
r
(k
D
a)
20
30
40
10
0
0.5
R
elative R
ayleigh ratio &
 dR
I
1.0
14.5 15.0 15.5
Elution volume (ml)
CDK
CtIP-nNTD
18-52
CtIP-cNTD
52-145
dc
A
bs
or
ba
nc
e
300
0
0.6
0.4
0.2
350 400 450 500 550 600
Wavelength (nm)
CtIP-cNTD
CtIP-cNTD-DM
(33% Zn2+)
(0.6% Zn2+)
(0-80 + M)
CtIP-nNTD
(0.4% Zn2+)
Zn2+
standards
Mr
Mr
coiled coilcoiled coil tetramerisation motif
Ý
N N
NN
C
C
C
C
C
CC
C
N
N
N
N
CtIP-nNTD (18 - 52)
Figure 2
NCN
C
a
b
c
F20
H31 V35
L38 V42
L45
N
N
C
C
W24F20
K28
N
C
NC
F20
C30
L23
L27
K28
W24
F20
L27 C30
F20L23
H31 V35 L38 V42 L45
Figure 3
ad
Mr
LS
dRI
0
M
ol
ec
ul
ar
 M
as
s,
 M
r
(k
D
a)
20
30
50
10
0.5
R
elative R
ayleigh ratio &
 dR
I
1.0
13.0 13.5
Elution volume (ml)
40
14.0
L27E
(15.9 kDa)
620-27
(14.8 kDa)
30.5 kDa
32.9 kDa
b
N N
N N
c
+ WT GFP-CtIP
WT L27
E
61-
140
WT L27
E
61-
140
WT
+ WT GFP-CtIP
GFP-CtIP
FLAG-CtIP
INPUTS IP: GFP
+ GFP
Figure 4
WT
L27E
inp.
8.3 8.9 9.5 10.1 10.7 11.3 11.9 12.5 13.1 Elution Volume, ml
Size markers, Mr (kDa)440 158
Estimated size, Mr (kDa)766 340
FLAG-CtIP
1 3 5 7 9 11 13 15 17
fractions
L27
cNTD
coiled-coil
(52-145)
nNTD
tetramer
(18-52)
1 897140
L27E
61-140
3xFLAG
3xFLAG
WT
3xFLAG
*
ab c
trunc eGFP (+1) T2A (+3) mCherry (+3)
✄ I-SceI
T2A (+3) mCherry (+3)
DSB
T2A (+3) mCherry (+3)
Homologous recombination (HR)
trunc eGFP (+1)
trunc eGFP (+1)
eGFP trunc (+1)
Exogenous donor template
eGFP (+1) T2A (+3) mCherry (+3)
T2A mCherrytrunc eGFP
Mutagenic end joining (mutEJ)
2 bp frameshift
GibberishFP (+3) T2A (+1) mCherry (+1)
GF
P-
po
sit
ive
 ce
lls
 (%
)
siLuciferase siCtIP
Homologous recombination
18
12
6
0 m
Ch
er
ry
-p
os
itiv
e 
ce
lls
 (%
)
siLuciferase siCtIP
Mutagenic end joining
4
3
2
1
0
EV WT L27E Δ1-140
FLAG-CtIP
%
 o
f c
on
tro
l
125
100
75
50
25
0
Homologous recombination
d
eGFP
✄
I-SceI
CGCGCCGAGtagggataacagggtaatCGCGCCGAG
STOP STOP 9bp homology
eGFP
MMEJ
CGCGCCGAG
18 nt deletion
9 bp homology
9bp homology
GF
P-
po
sit
ive
 ce
lls
 (%
)
0.0
0.5
1.0
1.5
siLuciferase siCtIP
0
20
40
60
80
100
EV WT L27E C2 Δ1-140
FLAG-CtIP
L27E C5
%
 o
f c
on
tro
l
Microhomology-mediated end joininge
MMEJ
aEV WT L27E
GFP-CtIP
EV WT L27E
GFP-CtIP
INPUTS IP: GFP
RAD50
MRE11
GFP (CtIP)
b
WT
GFP-CtIP γH2AX/cyclinA
L27E
G1
S/G2
G1
S/G2
24.9
0.5
RP
A2
 si
gn
al 
(a
.u
.)
Empty vector
31.0
WT
25.0
25.1
L27E
0.1
29.8
Δ1-140
1.4
DNA content (a.u.)
FLAG-CtIP
siLuciferase
siCtIP
%RPA+
cells
%RPA+
cells
RPA-positive cells (% of control)
EV WT L27E Δ1-140
FLAG-CtIP
100
60
40
20
0
80
d
NBS1
Untreated HU MMC
0
10
20
30
40
50
% GFP-CtIP-positive cells
CtIP WT
CtIP L27E
Untreated HU MMC
CtIP WT
CtIP L27E
0
20
40
60
80
% γH2AX-positive cells
c
Zinc-binding motif
89-CxxC-92
~300 Å 
Coiled-coilCoiled-coilTetramerisation domain
Figure 7
N
NN
N
C
C
C
C
CtIP
18 145
Supplementary Figure 1 
10 20 30 40 50 60 70 80
Hs
Mm
Ec
Oc
Gg
Xl
Dr
MN I LGSSCGSPNS AD - - - TSSDFKDLWTK LKECHDRE VQGLQVK VTK LKQER I LDAQRLEE FFTKNQQLREQQK VLHE T I K VLEDRLR
MS I SGSGCGSPNS AD - - - ASNDFKE LWTK LKE YHDKE VQGLQVK VTK LKKER I LDAQRLEE FFTKNQQLRDQQK VLQE T I K I LEDRLR
MS VSGSSSGSPSS AD - - - VSNDFKDLWTK LKE YHDKE VQGLQVK VTK LKKER I LDAQRLEE FFTKNQQLREQQK VLHE T I K VLEDRLR
MN I PGSNCGSPNSSE - - - TSNDFKDFWTK LKECHDKE VQGLQVK VTK LKKER I LDAQRLEE FFTKNQQLREQQK VLQE T I K VLEDRLR
MNASGGTCGSPSS AE - - P AGDFFKE LWSK LKECHDKE VQGLQLK I SK LKKERCLDAERLEE F YTKNQQLREQQK ALHDT I K VLEDRLR
MS I T AS TCGSPSSSES LPNGDL FKE LWSK LKECHDKDLQE L LMK I GK LKKERCLDAQRLEE F YTKNQHLREQQK TLHDT I K VLEDRLR
MS I TP ADLSP ASSSD - - - HREK LQE L L T AVRDLHDT ALQE LQAK I AK LKKERCLDAQK LSE FHSKNQHLREQQK I QQEK I RQLEDRLR
Coiled coil
Secondary structure
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - CCCCCCCCCCCCCCCCCCCCCCCCCCCC - -
100 110 120 130 140 150
AGLCDRCAVTEEHMRKKQQE FEN I RQQNLK L I TE LMNERNT LQEENKK LSEQLQQK I ENDQQHQAAE - - -
AGLCDRCAVTEEHMHKKQQE FEN I RQQNLK L I TE LMNEKNTLQEENKK LSEQLQQKMENGQQDQVAE - - -
AGLCDRCAVTEEHMRKKQQE FEN I RQQNLK L I TE LMNEKNTLQEENKK LSEQLQQK I ENDQQHQVTE - - -
AGLCDRCAVTEEHMRKKQQE FEN I RQQNLK L I TE LMNEKN I LQEENKK L LEQLQQK I ENDQQHQATE - - -
AGLCDRCAVTEEHMRKKQLE FEN I RQQNLK L I TE LMNEKNS LQDENKK I SEQFQQLQKE LEEQKQQA - - -
AGLCDRCTVTEEHMRKKQQE FEN I RQQNLK L I TE LMNDKNALQDENKRLSEQLHDMQKNRHRRKSDEENP
SGPCDCCTVKEKQ I KK TNTE LEDNNQRNLS V I SE LE AERK TL TDENRRLS LE LERLRRSGSPQNTSS - - -
  - - - - - - - - - - - - - - - - - - - - c c c c CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC - - - - - - - -
Hs
Mm
Ec
Oc
Gg
Xl
Dr
Mr
 
 (kDa)
14
39
28
19
NT
D
NT
D-
DM
cN
TD
cN
TD
-D
M
nN
TD
a
b
90
M
R
E
 [q
] (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-40
-20
0
60
40
20
190 200 210 220 230 240 250 260
Wavelength (nm)
_-helix
(nrmsd: 0.001)
73%
80
a b
c
e
d
M
R
E
 [q
] (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-40
-20
0
60
40
20
80
190 200 210 220 230 240 250 260
Wavelength (nm)
CtIP-NTD _-helix
(nrmsd: 0.002)
92%
CtIP-NTD-DM _-helix
(nrmsd: 0.003)
87%
M
R
E
 [q
] 22
2 (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-30
-20
-10
-40
0 20 40 60 80 100
Temperature (°C)
f
M
R
E
 [q
] (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-40
-20
0
60
40
20
190 200 210 220 230 240 250 260
Wavelength (nm)
_-helix
(nrmsd: 0.005)
94%
_-helix
(nrmsd: 0.005)
92%
80
M
R
E
 [q
] 22
2 (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-30
-20
-10
0
0 20 40 60 80 100
Temperature (°C)
M
R
E
 [q
] 22
2 (
x1
00
0 
de
g.
cm
2 .d
m
ol
-1
.re
si
du
e-
1 )
-30
-20
-10
0
0 20 40 60 80 100
Temperature (°C)
Supplementary Figure 2
CtIP-NTD
CtIP-NTD-DM
CtIP-cNTD
CtIP-cNTD-DM
CtIP-nNTD CtIP-nNTD
CtIP-cNTD
CtIP-cNTD-DM
Supplementary Figure 3
a 
1
100
1000
600 800 1000 1200 1400 1600 1800 2000 2200 2400 2600 2800 3000 3200 3400 3600
C 
N 
O 
K 
Br 
  0.50 C5N O 
  0.10 K Br 
  1.90 C 
C K Br S 
 
1
10
100
1000
10000
2 4 6 8 10 12 14 16
S 
Cl 
K 
Ca 
Cr 
Fe 
Zn 
Br 
b
Element 
Mass ra o 
to S (mean) 
Atomic ra o 
to Sulphur 
Mean MDL 
(at/S) Std Dev (rel %) 
Mean Į ng 
error% 
            
Al 0.243 0.288 2.266 173.2% 108.610 
Si 0.013 0.015 0.134   346.470 
P 0.005 0.006 0.086 173.2% 22.027 
S 1.000 1.000 0.028 0.0% 3.513 
Cl 0.042 0.038 0.025 58.1% 35.947 
K 9.601 7.857 0.028 57.5% 1.063 
Ca 0.058 0.047 0.038 37.1% 28.843 
Ti 0.006 0.004 0.010 109.9% 94.137 
Cr 0.061 0.038 0.027 134.4% 59.287 
Mn 0.000 0.000 0.010 173.2% 62.323 
Fe 0.033 0.019 0.010 46.1% 34.460 
Co 0.028 0.015 0.045 173.2% 56.577 
Ni 0.000 0.000 0.039   0.000 
Cu 0.017 0.009 0.014 87.1% 40.747 
Zn 0.195 0.095 0.024 25.2% 21.780 
Br 17.787 7.124 0.133 47.8% 4.267 
c
R
elative R
ayleigh ratio &
 dR
I
LS
dRI
187 kDa
0
M
ol
ec
ul
ar
 m
as
s 
(k
D
a)
150
200
250
100
0
0.5
1.0
Elution volume (ml)
50
10.0 12.0 14.0
44.5 kDa
MBP-CtIP-nNTD
(49.2 kDa)
MBP
(44.7 kDa)
Supplementary Figure 4
Mr
Supplementary Figure 5
aS
id
e 
sc
at
te
r (
S
S
-A
)
Forward scatter (FS-A)
S
id
e 
sc
at
te
r (
S
S
-W
)
Forward scatter (FS-A)
c d
e
BFP 405 (450/50)
IF
P 
64
0 
(7
30
/4
5)
GFP 488 (530/30)
m
C
he
rr
y 
56
1 
(6
10
/2
0)
f
GFP 488 (530/30)
m
C
he
rr
y 
56
1 
(6
10
/2
0)
g
C
ou
nt
s
BFP 405 (450/50)
h
trunc eGFP (+1) T2A (+3) mCherry (+3)
 I-SceI (IFP vector)
T2A (+3) mCherry (+3)
DSB
T2A (+3) mCherry (+3)
Homologous recombination (HR)
trunc eGFP (+1)
trunc eGFP (+1)
eGFP trunc (+1) Exogenous donor template (BFP vector)
eGFP (+1) T2A (+3) mCherry (+3)
T2A mCherrytrunc eGFP
Mutagenic end joining (mutEJ)
2 bp frameshift
GibberishFP (+3) T2A (+1) mCherry (+1)
0 6
siRNA
transfection
Donor + I-SceI
transfection
24
Wash
72 Collect and FACS
analysis
time (h)
b
Supplementary Figure 6
EV WT L27E 61-140
FLAG-CtIP
%
 o
f c
on
tro
l
Mutagenic end-joining
125
100
150
Supplementary Figure 7
WT C5 C2 61-140
L27EEmpty
vector
siCtIP - + + + + +
CtIP
FLAG-CtIP
FLAG-CtIP
PARP-1
Supplementary Figure 8
Untreated HU 1 mM 24h MMC 120 ng/ml 24h
GF
P-
Ct
IP
 si
gn
al 
(lo
g 
sc
ale
)
aH
2A
X 
sig
na
l (
log
 sc
ale
)
DNA content (a.u.)
WT 
GFP-CtIP
Untreated HU 1 mM 24h MMC 120 ng/ml 24h
GF
P-
Ct
IP
 si
gn
al 
(lo
g 
sc
ale
)
aH
2A
X 
sig
na
l (
log
 sc
ale
)
DNA content (a.u.)
L27E
GFP-CtIP
GFP-CtIP
RPA2
GFP WT L27E
a GFP-CtIP
b
Supplementary Figure 9
 R
PA
2:
 A
le
xa
 F
lu
or
 4
88
 (5
30
/5
40
)
Untreated CPT
siLuciferase
Untreated CPT
siCtIP
 g
H
2A
X
: A
le
xa
 F
lu
or
 5
94
 (6
10
/6
20
)
C
on
tro
l
 R
PA
2:
 A
le
xa
 F
lu
or
 4
88
 (5
30
/5
40
)
 g
H
2A
X
: A
le
xa
 F
lu
or
 5
94
 (6
10
/6
20
)
 R
PA
2:
 A
le
xa
 F
lu
or
 4
88
 (5
30
/5
40
)
 g
H
2A
X
: A
le
xa
 F
lu
or
 5
94
 (6
10
/6
20
)
 R
PA
2:
 A
le
xa
 F
lu
or
 4
88
 (5
30
/5
40
)
 g
H
2A
X
: A
le
xa
 F
lu
or
 5
94
 (6
10
/6
20
)
DAPI (Area) (450/50)
FL
A
G
-C
tIP
 W
T
FL
A
G
-C
tIP
 L
27
E
FL
A
G
-C
tIP
 6
1-
14
0
Supplementary Figure 10
F20E CtIP-NTD (15.8 kDa)
LS
dRI
62.3 kDa
33.2 kDa
0
M
ol
ec
ul
ar
 m
as
s,
 M
r  
(k
D
a)
40
60
100
20
0
0.5
R
elative R
ayleigh ratio &
 dR
I
1.0
11.0 12.0 14.0
Elution volume (ml)
80
13.0
Supplementary Figure 11
Mr
NTD CTD
- -
CtIP1 145 769 897
Supplementary Figure 12
[protein]
b
full-length CtIP
¶GLPHURIGLPHUV·
CTD
MRE11-RAD50
N
C MRE11
MRE11
N
N
C
C
CTD
CTD
CTD
MRE11
MRE11
N
C
~600 Å 
a
